The German fibromyalgia consumer reports – a cross-sectional survey
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Consumer surveys provide information on effectiveness and side effects of medical interventions in routine clinical care. A report of fibromyalgia syndrome (FMS) consumers has not been carried out in Europe. Methods: The study was carried out from November 2010 to April 2011. Participants diagnosed with FMS rated the effectiveness and side effects of pharmacological and non-pharmacological FMS interventions on a 0 to 10 scale, with 10 being most efficacious (harmful). The questionnaire was distributed by the German League for people with Arthritis and Rheumatism and the German Fibromyalgia Association to their members and to all consecutive FMS patients of nine clinical centers of different levels of care. Results: 1661 questionnaires (95% women, mean age 54 years, mean duration since FMS diagnosis 6.8 years) were analysed. The most frequently used therapies were self-management strategies, prescription pain medication and aerobic exercise. The highest average effectiveness was attributed to whole body and local warmth therapies, thermal bathes, FMS education and resting. The highest average side effects were attributed to strong opioids, local cold therapy, gamma-amino-butyric acid analogues (pregabalin and gabapentin), tramadol and opioid transdermal systems. Conclusion: The German fibromyalgia consumer reports highlight the importance of non-pharmcological therapies in the long-term management of FMS, and challenges the strong recommendations for drug therapies given by FMS-guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ–4
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2009) · Psychosomatics · doi:10.1016/s0033-3182(09)70864-3 · Cited by 4,261
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 2×
“Background The key symptoms of fibromyalgia syndrome (FMS) are chronic widespread pain, unrefreshed sleep, cognitive dysfunction and fatigue [1,2].”
BackgroundMethodSelf-citationLöwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., Schneider, A., & Brähler, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.019 · Cited by 2,473
WOLFE, F., CLAUW, D. J., FITZCHARLES, M.-A., GOLDENBERG, D. L., HÄUSER, W., KATZ, R. S., MEASE, P., RUSSELL, A. S., RUSSELL, I. J., & WINFIELD, J. B. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100594 · Cited by 1,499
Self-citationAn internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865 · cited 2×
“Table 5 Comparison of selected management strategies currently used by US- (members of the National Fibromyalgia Association) (N= 2596) [14] and German FMS-consumers (N=1661) (in descending order of frequency according to US-survey) [14] (0 =no effectiveness or harm; 10 =maximum effectiveness or harm) Management strat…”
MethodResultEULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
A patient survey of the impact of fibromyalgia and the journey to diagnosis
Choy, E., Perrot, S., Leon, T., Kaplan, J., Petersel, D., Ginovker, A., & Kramer, E. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-102 · Cited by 305
Häuser, W., Zimmer, C., Felde, E., & Köllner, V. (2008) · Der Schmerz · doi:10.1007/s00482-007-0602-z · Cited by 124 · cited 1×
“Background The key symptoms of fibromyalgia syndrome (FMS) are chronic widespread pain, unrefreshed sleep, cognitive dysfunction and fatigue [1,2].”
BackgroundSelf-citationHäuser, W., Eich, W., Herrmann, M., Nutzinger, D. O., Schiltenwolf, M., & Henningsen, P. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0383 · Cited by 88
Self-citation
Cited by
2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria
Wolfe, F., Clauw, D. J., Fitzcharles, M.-A., Goldenberg, D. L., Häuser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.08.012 · Cited by 2,232
Self-citationHäuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.22 · Cited by 505
Self-citationReview of pharmacological therapies in fibromyalgia syndrome
Häuser, W., Walitt, B., Fitzcharles, M.-A., & Sommer, C. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4441 · Cited by 188
“Forty-one percent of the participants of the German FMS consumer reports were current users of NSAIDs [10], whereas in the US, 36% report current use of ibuprofen [9].”
BackgroundMethodResultInfluentialSelf-citationZech, N., Hansen, E., Bernardy, K., & Häuser, W. (2017) · European Journal of Pain · doi:10.1002/ejp.933 · Cited by 111
Self-citationBernardy, K., Klose, P., Welsch, P., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1284 · Cited by 50
Metadata
- Authors
- Häuser, W., Jung, E., Erbslöh-Möller, B., Gesmann, M., Kühn-Becker, H., Petermann, F., Langhorst, J., Thoma, R., Weiss, T., Wolfe, F., & Winkelmann, A.
- Venue
- BMC Musculoskeletal Disorders
- Published
- 2012-05-18
- Volume
- 13
- Issue
- 1
- Pages
- 74-74
- ISSN
- 1471-2474 (ISSN-L)
- OpenAlex
- W2163576272
- Cited by
- 74
- References
- 9
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The German fibromyalgia consumer reports – a cross-sectional survey. https://app.cochat.ai/papers/10.1186/1471-2474-13-74
- The paper
- Häuser, W., Jung, E., Erbslöh-Möller, B., Gesmann, M., Kühn-Becker, H., Petermann, F., Langhorst, J., Thoma, R., Weiss, T., Wolfe, F., & Winkelmann, A. (2012). The German fibromyalgia consumer reports – a cross-sectional survey. BMC Musculoskeletal Disorders. https://doi.org/10.1186/1471-2474-13-74
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.